FDA Approves New Biologic for Atopic Dermatitis in Children FDA Approves New Biologic for Atopic Dermatitis in Children

Dupilumab (Dupixent) injection has been approved for adults since 2017. The new indication is for children whose atopic dermatitis is not adequately controlled with topical prescription therapies.FDA Approvals
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Alert Source Type: news